Dow Up 0.11% Nasdaq Up 0.50%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.70 Down 0.03(0.52%) Aug 29, 4:00PM EDT
|After Hours : 5.71 Up 0.01 (0.18%) Aug 29, 7:58PM EDT
Prev Close:5.73
Open:5.74
Bid:5.71 x 300
Ask:N/A
1y Target Est:9.75
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.57 - 5.75
52wk Range:4.60 - 7.82
Volume:4,160,719
Avg Vol (3m):3,555,750
Market Cap:698.44M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 0.52%698.44M
ABTDown 0.26%63.52B
GSKUp 0.47%117.94B
RHHBYDown 0.14%248.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):204.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback